Evidence for the renal paratubular transport of glutathione  by Rankin, Barbara B. & Curthoys, Norman P.
Volume 147, number 2 FEBSLETTERS October 1982 
Evidence for the renal paratubular transport of glutathione 
Barbara B. Rankin and Norman P. Curthoys 
Department of Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA 
Received 3September 1982 
Glutathione y-Gutamyltranspeptidase Paratubular transport 
Basolateral membrane 
Kidney Proximal tubule 
1. INTRODUCTION 
The catabolism of glutathione in various non- 
renal tissues occurs through an interorgan process 
[ 1,2]. For example, the turnover of glutathione 
within rat liver is initiated by the unidirectional 
release of glutathione to the blood plasma [3]. The 
released glutathione is carried to the kidney where 
it is nearly quantitatively extracted and degraded 
to its constituent amino acids [4,5]. The glu- 
tathionemia and the pronounced glutathionuria 
observed in a patient who lacks detectable -r-glu- 
tamyltranspeptidase [6] and in mice treated with 
inhibitors of y-glutamyltranspeptidase [7,8] indi- 
cate that this enzyme catalyzes the initial reaction 
in glutathione catabolism. The transpeptidase is an 
amphipathic membrane glycoprotein [9] that is 
found to the greatest extent in the kidney. Within 
this tissue, the enzyme is primarily associated with 
the brush border membrane of the proximal tu- 
bule cells [lo], where it is asymmetrically orien- 
tated on the lumenal surface [ 111. 
the glomeruli even when the arterial glutathione 
concentration is increased to a value 200-fold 
greater than normal [5]. Therefore, the kidney may 
contain a mechanism for the transport of glu- 
tathione across the basolateral plasma membrane. 
However, small amounts of y-glutamyltranspep- 
tidase may be associated with the glomeruli [13], 
with the renal microvasculature [14], or with the 
basolateral membrane of the proximal tubule [ 151. 
Thus, the apparent extraction of glutathione by the 
kidney may be due to its catabolism within the 
post-glomerular paratubular space. In order to re- 
solve these two possibilities, we have used the pro- 
cedures in [16] to study the renal paratubular 
handling of glutathione. 
2. MATERIALS AND METHODS 
Glutathione contained within the kidney also 
turns over rapidly [ 121. The initial step in this pro- 
cess is the translocation of glutathione from the 
epithelial cells to the tubular lumen [7,8]. Here, the 
secreted renal glutathione is degraded and the re- 
sulting amino acids presumably enter the same 
pool as produced by the degradation of non-renal 
glutathione. Reabsorption of the amino acids and 
their redistribution for protein synthesis or the re- 
synthesis of glutathione completes the interorgan 
metabolism of glutathione. 
White male rats (150-250 g) were obtained 
from Zivic Miller and were maintained on Purina 
Rat Chow. All of the radioisotopes used in these 
experiments were purchased from New England 
Nuclear. The AT-125 (L-(crS,SS)-a-amino-3-chlo- 
ro-4,5-dihydro-5-isoxazoleacetic acid) was ob- 
tained from Dr Ruth Davis of the National Cancer 
Institute. v-Glutamyltranspeptidase activity [ 171 
and glutathione concentration [18] were deter- 
mined as described. 
The percent of plasma glutathione extracted by 
the kidney greatly exceeds the percent filtered by 
To study the paratubular handling of glu- 
tathione, rats were initially anesthetized with so- 
dium pentothal and injected with heparin. Can- 
nulae were inserted into the abdominal aorta and 
the inferior vena cava below the left kidney. Liga- 
tures were then tied around the coeliac, mesenteric 
and right renal arteries and around the vena cava 
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just above the left renal vein. A 50 ~1 sample con- 
taining [Wlinulin and [glycin&H]glutathione 
was injected into the aorta and the entire effluent 
from the vena cava was collected dropwise into 
separate scintillation vials. The drops of blood 
were solubilized with NCS tissue solubilizer, clear- 
ed with Hz02 and diluted with ACS scintillation 
solution. The 3H and 14C radioactivities were de- 
termined for each sample and the ratio of counts 
was normalized by dividing by the 3H/l4C ratio 
determined for the sample initially injected. A val- 
ue of < 1 for the normalized ratio indicates that 
the substance being studied is transported out of 
the post-glomerular paratubular space [ 161. 
3. RESULTS AND DISCUSSION 
The validity of the single-pass perfusion tech- 
nique for studying paratubular transport was ini- 
tially established by arterial infusion of a sample 
containing p-amino[l‘W]hippurate and [3H]inulin 
(tig.1). The [3H]inulin was recovered in the venous 
effluent as a single peak of radioactivity. However, 
a much smaller proportion of the injected 
p-amino[l‘W]hippurate was recovered. The nor- 
malized t‘W3H ratio for the collected samples 
varied from 0.1-0.2 indicating that > 80% of the p- 
aminohippurate contained in the paratubular 
blood was extracted across the basolateral plasma 
membrane. This result is consistent with experi- 
ments characterizing the paratubular uptake of p- 
aminohippurate [ 191. 
The paratubular extraction of glutathione was 
then characterized by infusion of a sample con- 
taining [glycine-3H]glutathione and [Wlinulin 
(fig.2). The recovery of 3H radioactivity was sig- 
nificantly decreased compared to the recovery of 
[t‘W]inulin. The initial fractions collected from the 
venous effluent exhibited a 3H/l4C ratio of only 
0.25. However, in later fractions, the radioactivity 
ratio increased steadily and it reached a value of 
0.9 in the last sample collected. The observed pat- 
tern indicates that glutathione may be efficiently 
transported across the basolateral membrane. The 
increase in the 3H/t4C ratio observed in the later 
fractions could indicate that the extracted glu- 
tathione is metabolized and the resulting products 
are returned to the paratabular circulation. 
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Fig. 1. Renal paratubular extraction of p-aminohippur- 
ate. A 50 &sample containing p-amino[t4C]hippurate 
(PAH) and [sH]inulin was injected into the abdominal 
aorta and the total effluent from the renal vein was col- 
lected dropwise. The t4C/3H ratio for each fraction was 
normalized by dividing by the r‘%/sH ratio of radio- 
Fig.2. Renal paratubular extraction of glutathione. 
A 50 ~1 sample containing (&cine-3Hlglutathione 
(GSH) and [tdC]inulin was injected into the abdominal 
aorta of an untreated rat. The 3H/t4C ratio for each 
fraction was normalized by dividing by the 3H/ t4C ratio 
activity contained in the initial sample. of radioactivity contained in the initial sample. 
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Fig.3. Renal paratubular extraction of glutathione in an 
AT-125treated rat. The experiment was done as in fig.2 
except that the rat received an i.v. injection of 
0.05 mmol AT-125/kg body wt 1 h before infusion of 
labeled glutathione (GSH). 
However, the observed results are also consistent 
with the catabolism of glutathione within the para- 
tubular plasma and the partial extraction of the 
resulting amino acids. 
To distinguish between the 2 alternative pos- 
sibilities, rats were pretreated with AT-125. This 
compound is a potent affinity label, which causes 
the in vivo inactivation of y-glutamyltranspep- 
tidase [20]. Renal y-glutamyltranspeptidase is in- 
hibited 98% within 1 h after injecting AT-125 (ta- 
ble 1). This treatment has no effect on the plasma 
concentration or the urinary excretion of amino 
acids. However, it does result in a 3000-fold in- 
crease in the urinary concentration of glutathione 
indicting that a physiologically significant propor- 
tion of the y-glutamyltranspeptidase activity is in- 
hibited. AT-125 treatment also produces a signifi- 
cant increase (2.5-fold) in the arterial concentra- 
tion of glutathione. A comparison of arterial and 
renal venous concentrations indicates that the inhi- 
bition of y-glutamyltranspeptidase has little effect 
on the ability of the kidney to extract plasma glu- 
tathione. The 73% extraction observed in AT-125- 
Table 1 
Effect of inactivation of y-glutamyltranspeptidase on the 
renal handling of glutathione 
Parameter Normal AT-125 
treateda 
yGT Activity 
(pmol/min . mg) 
Urinary [GSH] 
(/.W 
1.23 + 0.08 0.026 2 0.006 









a y-glutamyltranspeptidase (yGT) activity and plasma 
levels of glutathione (GSH) were determined 1 h after 
an i.v. injection of 0.05 mmol AT-125/kg body wt, 
whereas urinary glutathione was determined on 
samples collected for 4 h 
treated rats greatly exceeds the proportion of plas- 
ma glutathione removed by glomerular filtration. 
These results are in contrast to those reported in 
[21], which used a 50-fold greater dose of AT-125 
and observed that renal extraction of glutathione 
was decreased to 39% while the y-glutamyltrans- 
peptidase activity was inhibited only 90-95s. 
When used in high concentrations AT-125 be- 
comes a non-specific alkylating agent [22], that 
may inhibit the paratubular transport system for 
glutathione. 
The paratubular extraction of glutathione was 
then characterized in AT-125-treated rats. The 
data shown in fig.3 indicate that compared to the 
recovery of [14C]inulin a significant extraction of 
[3H]glutathione was still observed. The normalized 
3H/r4C ratio observed in the initial fraction was 
0.4. However, this ratio increased in later fractions 
and it reached a value slightly greater than 1. Since 
98% of the y-glutamyltranspeptidase activity was 
inhibited in this experiment, it is unlikely that the 
labeled glutathione released to the paratubular cir- 
culation is catabolized. The observation that AT- 
125 treatment does not block renal extraction or 
paratubular uptake of glutathione provides strong 
evidence for the existence of a transport system for 
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glutathione within the basolateral membrane. It is 
now important to characterize the specificity of 
this transport system to determine if it can account 
for the ability of the kidney to extract various y- 
glutamyl compounds from the blood [23,24]. 
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